NCT05832346 - Clinical Trial References

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Citation(s)

Hall, L
; Hume, C.; Tazzyman, S. Five degrees of happiness: Effective Smiley Face Likert Scales for evaluating with children. In Proceedings of the 15th International Conference on Interaction Design and Children, Manchester, UK, 21-24 June 2016; pp. 311-321. https://dl.acm.org/doi/proceedings/10.1145/2930674
Marteau TM, Bekker H
The development of a six-item short-form of the state scale of the Spielberger State-Trait Anxiety Inventory (STAI). Br J Clin Psychol. 1992 Sep;31(3):301-6. doi: 10.1111/j.2044-8260.1992.tb00997.x. Erratum In: Br J Clin Psychol. 2020 Jun;59(2):276.
Wilson D, Cutts J, Lees I, Mapungwana S, Maunganidze L
Psychometric properties of the revised UCLA Loneliness Scale and two short-form measures of loneliness in Zimbabwe. J Pers Assess. 1992 Aug;59(1):72-81. doi: 10.1207/s15327752jpa5901_7.

Preliminarily Effects of a Laughter Yoga Program on the Mood, Anxiety, and Loneliness Among Adolescents With Intellectual and Physical Disabilities in a Special School: a Pilot Randomized Controlled Trial

Details for clinical trial NCT05832346

Clinical trial NCT05832346 - References